Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Annie-Claire Diserens"'
Autor:
Silvia Hofer, Luigi Mariani, Karl Frei, Adrian Merlo, Yasuhiro Yonekawa, Frank L. Heppner, Arend Koch, Matthias S. Matter, Marie-France Hamou, Wanyu L. Lambiv, Mauro Delorenzi, Mathilde C. M. Kouwenhoven, Yuta Kamoshima, Pierre Bady, Annie-Claire Diserens, Monika E. Hegi
Supplementary Methods, Figure Legends 1-5 from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e98b95440308927845df74b2956ae87
https://doi.org/10.1158/1535-7163.22496533.v1
https://doi.org/10.1158/1535-7163.22496533.v1
Autor:
Silvia Hofer, Luigi Mariani, Karl Frei, Adrian Merlo, Yasuhiro Yonekawa, Frank L. Heppner, Arend Koch, Matthias S. Matter, Marie-France Hamou, Wanyu L. Lambiv, Mauro Delorenzi, Mathilde C. M. Kouwenhoven, Yuta Kamoshima, Pierre Bady, Annie-Claire Diserens, Monika E. Hegi
Supplementary Figure 2 from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a167f30be0851324e54af2254f32854
https://doi.org/10.1158/1535-7163.22496548
https://doi.org/10.1158/1535-7163.22496548
Autor:
Silvia Hofer, Luigi Mariani, Karl Frei, Adrian Merlo, Yasuhiro Yonekawa, Frank L. Heppner, Arend Koch, Matthias S. Matter, Marie-France Hamou, Wanyu L. Lambiv, Mauro Delorenzi, Mathilde C. M. Kouwenhoven, Yuta Kamoshima, Pierre Bady, Annie-Claire Diserens, Monika E. Hegi
Supplementary Table 1 from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fc6ef17600cd0c658f260ffb1ef3544
https://doi.org/10.1158/1535-7163.22496530
https://doi.org/10.1158/1535-7163.22496530
Autor:
Silvia Hofer, Luigi Mariani, Karl Frei, Adrian Merlo, Yasuhiro Yonekawa, Frank L. Heppner, Arend Koch, Matthias S. Matter, Marie-France Hamou, Wanyu L. Lambiv, Mauro Delorenzi, Mathilde C. M. Kouwenhoven, Yuta Kamoshima, Pierre Bady, Annie-Claire Diserens, Monika E. Hegi
Supplementary Figure 5 from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63354b5b7f95265360173c47fe71006d
https://doi.org/10.1158/1535-7163.22496536.v1
https://doi.org/10.1158/1535-7163.22496536.v1
Autor:
Silvia Hofer, Luigi Mariani, Karl Frei, Adrian Merlo, Yasuhiro Yonekawa, Frank L. Heppner, Arend Koch, Matthias S. Matter, Marie-France Hamou, Wanyu L. Lambiv, Mauro Delorenzi, Mathilde C. M. Kouwenhoven, Yuta Kamoshima, Pierre Bady, Annie-Claire Diserens, Monika E. Hegi
Supplementary Table 2 from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8584e250758df6769b27bf0e2a92cfda
https://doi.org/10.1158/1535-7163.22496527.v1
https://doi.org/10.1158/1535-7163.22496527.v1
Autor:
Silvia Hofer, Luigi Mariani, Karl Frei, Adrian Merlo, Yasuhiro Yonekawa, Frank L. Heppner, Arend Koch, Matthias S. Matter, Marie-France Hamou, Wanyu L. Lambiv, Mauro Delorenzi, Mathilde C. M. Kouwenhoven, Yuta Kamoshima, Pierre Bady, Annie-Claire Diserens, Monika E. Hegi
Amplification of the epidermal growth factor receptor (EGFR) gene is one of the most common oncogenic alterations in glioblastoma (45%) making it a prime target for therapy. However, small molecule inhibitors of the EGFR tyrosine kinase showed disapp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27bf4d567440cf1976ec5780e2d74891
https://doi.org/10.1158/1535-7163.c.6535309
https://doi.org/10.1158/1535-7163.c.6535309
Autor:
Silvia Hofer, Luigi Mariani, Karl Frei, Adrian Merlo, Yasuhiro Yonekawa, Frank L. Heppner, Arend Koch, Matthias S. Matter, Marie-France Hamou, Wanyu L. Lambiv, Mauro Delorenzi, Mathilde C. M. Kouwenhoven, Yuta Kamoshima, Pierre Bady, Annie-Claire Diserens, Monika E. Hegi
Supplementary Figure 3 from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4030d86fd9399c59ca9b1a236adf1755
https://doi.org/10.1158/1535-7163.22496545
https://doi.org/10.1158/1535-7163.22496545
Autor:
Silvia Hofer, Luigi Mariani, Karl Frei, Adrian Merlo, Yasuhiro Yonekawa, Frank L. Heppner, Arend Koch, Matthias S. Matter, Marie-France Hamou, Wanyu L. Lambiv, Mauro Delorenzi, Mathilde C. M. Kouwenhoven, Yuta Kamoshima, Pierre Bady, Annie-Claire Diserens, Monika E. Hegi
Supplementary Figure 4 cont. from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69a022c1de4e690eed6133f930d65657
https://doi.org/10.1158/1535-7163.22496542
https://doi.org/10.1158/1535-7163.22496542
Autor:
Silvia Hofer, Luigi Mariani, Karl Frei, Adrian Merlo, Yasuhiro Yonekawa, Frank L. Heppner, Arend Koch, Matthias S. Matter, Marie-France Hamou, Wanyu L. Lambiv, Mauro Delorenzi, Mathilde C. M. Kouwenhoven, Yuta Kamoshima, Pierre Bady, Annie-Claire Diserens, Monika E. Hegi
Supplementary Figure 1 from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7491eb3d6af1427533a39bfa3348bb60
https://doi.org/10.1158/1535-7163.22496551
https://doi.org/10.1158/1535-7163.22496551
Autor:
Silvia Hofer, Luigi Mariani, Karl Frei, Adrian Merlo, Yasuhiro Yonekawa, Frank L. Heppner, Arend Koch, Matthias S. Matter, Marie-France Hamou, Wanyu L. Lambiv, Mauro Delorenzi, Mathilde C. M. Kouwenhoven, Yuta Kamoshima, Pierre Bady, Annie-Claire Diserens, Monika E. Hegi
Supplementary Figure 4 from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e01fde59480b403c5152970d783518d
https://doi.org/10.1158/1535-7163.22496539.v1
https://doi.org/10.1158/1535-7163.22496539.v1